Investment
Features
FeesSafety
Academy
More
Pluang+
Asset icon - trade crypto, stocks, and gold on Pluang

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

ALNY trades at $288.06, down 3.58% today, with a bullish technical signal supported by oscillators and strong institutional sentiment. The company reported robust revenue growth to $3.71B in 2025, turning profitable with net income of $313.75M, and shows a positive earnings beat trend. Recent news highlights pipeline advancements and strategic AI partnerships aimed at accelerating drug discovery.
Outlook remains positive with a consensus price target of $414.40, implying 44% upside, driven by pipeline diversification and market expansion. Key risks include clinical trial outcomes and dependence on key drug Amvuttra. Wall Street maintains strong buy consensus (75% buy ratings) amid expectations for sustained growth and potential S&P 500 inclusion.
Read full analysis

Key Stats

  • Market Cap
    $39.89B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $491.22
  • 52W Low
    $278.09
  • Typical Hold Time
    -
  • Enterprise Value
    $38.15B
  • Div Yield
    -
  • Trading Activity
    -
$288.06
52W Low: $278.09
18 Jun 2026
52W High: $491.22
20 Oct 2025

Track Alnylam Pharmaceuticals, Inc. (ALNY) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Alnylam Pharmaceuticals, Inc. has traded between a low of $278.09 and a high of $491.22, highlighting its annual price range. Buy and sell Alnylam Pharmaceuticals, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.


People also bought


Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Key Stats

  • Market Cap
    $39.89B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $491.22
  • 52W Low
    $278.09
  • Typical Hold Time
    -
  • Enterprise Value
    $38.15B
  • Div Yield
    -
  • Trading Activity
    -
$288.06
52W Low: $278.09
18 Jun 2026
52W High: $491.22
20 Oct 2025

Track Alnylam Pharmaceuticals, Inc. (ALNY) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Alnylam Pharmaceuticals, Inc. has traded between a low of $278.09 and a high of $491.22, highlighting its annual price range. Buy and sell Alnylam Pharmaceuticals, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!